title: Human insulin: a biotechnological scapegoat?
authors.affiliation: Novo Nordisk Pharmaceuticals Pty Ltd, North Rocks, N.S.W.
authors.forename: J J
authors.initials: JJ
authors.lastname: Miller
authors.forename: S
authors.initials: S
authors.lastname: Colagiuri
mesh_terms: D000818:Animals; D001364:Awareness; D001709:Biotechnology; D003920:Diabetes Mellitus / Q000188:drug therapy; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007328:Insulin / Q000009:adverse effects* / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use*; D013552:Swine
chemical_list: D007328:Insulin; D011994:Recombinant Proteins